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Abstract: Clinical ﬁ  ndings and treatment of keratomycosis caused by Beauveria bassiana, 
an entomopathogenic ﬁ  lamentous fungus, are described for an 80-year-old woman, who was 
referred to the hospital for ocular pain and redness on the 9th day after an ocular injury caused 
by the frame of her glasses. She had a long history of recurrent diabetic iritis and continuously 
used topical antibiotics and corticosteroids. At her ﬁ  rst visit, a slit-lamp examination indicated 
a corneal ulcer conﬁ  ned within the superﬁ  cial stromal layer, along with a slight inﬁ  ltration and 
edema. Only a very few inﬂ  ammatory cells were seen in the anterior chamber. Direct microscopic 
examination of corneal scrapings revealed septate fungal hyphae with zig-zag rachis and bud-
ding that was subsequently identiﬁ  ed as B. bassiana by slide culture. Topical voriconazole with 
miconazole, pimaricin and oral itraconazole were effective and the lesion disappeared leaving 
only a mild scar at 2 months. The sensitivity of B. bassiana to various antimycotic agents was 
conﬁ  rmed by broth microdilution, agar dilution with the Clinical Laboratory Standard Institute 
standard, and a disk method using topically applied concentrations. B. bassiana, which exhib-
its a characteristic appearance in smears and causes superﬁ  cial keratomycosis, is sensitive to 
voriconazole with miconazole, pimaricin, and itraconazole.
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Introduction
Keratomycosis caused by ﬁ  lamentous fungi rapidly progress deep into the stroma with 
edematous inﬁ  ltrations, often accompanied by a severe anterior chamber inﬂ  amma-
tion. In contrast, some species of ﬁ  lamentous fungi, such as Alternaria, can cause mild 
superﬁ  cial corneal infections. Unfortunately, these are frequently misdiagnosed as a 
bacterial corneal infection (Suzuki et al 2004). Here, we report a superﬁ  cial kerato-
mycosis caused by the ﬁ  lamentous fungus, Beauveria bassiana (B. bassiana), and its 
successful treatment with voriconazole (VCZ).
Case report
An 80-year-old woman struck her left eye with the frame of her glasses. Due to 
continuing ocular pain and hyperemia, she was referred to our hospital 9 days after 
the original injury. The patient was also suffering from recurrent diabetic iritis and 
continuously used topical antibiotics and corticosteroids. At the time of her ﬁ  rst visit 
to our hospital, there was ulceration of the corneal epithelium at the 5 o’clock region 
along with slight superﬁ  cial inﬁ  ltration, slight edema, and ciliary injection. No endo-
thelial plaques or any immune rings were noted. Although a part of the Descemet’s 
membrane was folded, there was only slight anterior chamber inﬂ  ammation (Figure 1). 
A corneal scraping smear indicated the presence of Gram-positive fungal septate Clinical Ophthalmology 2008:2(3) 676
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hyphae with budding (Figure 2a), which led to a diagnosis 
of keratomycosis by ﬁ  lamentous fungus. Positive staining 
by Fungiﬂ  ora Y also supported the keratomycosis diagnosis. 
From the culture of the corneal scraping, we were able to 
isolate a whitish yellow colony, with the fungus exhibiting 
zigzag rachis and oval conidia, which are characteristics 
of B. bassiana in slide cultures (Figure 2b). Two different 
microbiology laboratories, the Department of the Labora-
tory for Clinical Investigation at Osaka University Hospital 
and the Chiba University Research Center for Pathogenic 
Figure 1 At the patient’s ﬁ  rst visit to our hospital, a slit lamp examination showed a temporal corneal ulcer at the 5 o’clock position. The lesion was restricted to the superﬁ  cial 
stromal layer, with no endothelial plaque and very little anterior chamber inﬂ  ammation.
Figure 2 a Gram staining of the corneal scraping smear shows septate hyphae. Arrows indicate budding. b Beauveria bassiana cultured on a slide. Note the zig-zag rachis 
(arrowheads) and oval conidia.
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Fungi and Microbial Toxicoses, independently conﬁ  rmed the 
presence of the organism. Any other organisms were detected 
by the culture of corneal scraping. The patient was managed 
with topical 0.1% miconazole (MCZ), 1% VCZ once an 
hour, and 1% pimaricin (PMR) ointment administered once 
a day along with oral itraconazole (ITCZ: 100 mg/day). 
Although there was gradual amelioration of the lesion, the 
presence of a band-shaped calcium deposit interrupted the 
re-epithelization, requiring the deposit to be scraped off on 
two different occasions during the healing process. The lesion 
healed with only mild scarring remaining after two months. 
In order to determine the minimum inhibitory concentration 
(MIC) required for each of the antimycotic agents, ASTY 
and E-test in vitro susceptibility tests were performed. The 
results for the MIC tests were: amphotericin-B: 8.0, 5-FC: 
64, ﬂ  uconazole (FCZ): 256, ITCZ: 0.25, MCZ: 0.5, mica-
fangin (MCFG): 0.5, and VCZ: 0.5 (μg/ml). In addition, 
the organism was also found to be susceptible to topically 
applied antimycotic agents that included, 0.5% VCZ, 5% 
PMR, and 0.5% MCZ, which were administered by the disk 
method (Figure 3).
Discussion
This is the ﬁ  rst report of a successful VCZ treatment of B. 
bassiana keratomycosis. VCZ is a powerful antimycotic 
agent that is used against ﬁ  lamentous fungi (Ozbek et al 2006; 
Sponsel et al 2006; Bunya et al 2007; Lee et al 2007; Thiel 
et al 2007). Although treatments of ﬁ  ve cases of Beauveria 
corneal infection, four cases of B. bassiana, and one case 
of B. alba have been previously reported, for most of these 
patients, they also required an additional surgical procedure, 
such as penetrating keratoplasty or keratectomy, to com-
pletely manage the keratomycosis (Ishibashi et al 1984; 
McDonnell et al 1984; Sachs et al 1985; Low et al 1997; 
Kisla et al 2000). In order for a successful treatment to be 
performed without any additional surgical procedures, there 
needs to be an effective therapeutic regimen for antimycotic 
agents that can be applied in cases involving ﬁ  lamentous 
fungi. For example, in the present case, we administered 
VCZ and our data indicated that VCZ might have been 
the crucial factor that was responsible for the success of 
the treatment. We decided to conﬁ  rm the sensitivity of the 
antimycotic agents at their topically applied concentrations, 
Figure 3 The disk sensitivity test using topically applied antimycotic agents. A 0.05% solution of VCZ was used because the 1% VCZ caused a large inhibition circle. PMR eye 
drops (5%) were used instead of ointment (1%). VCZ, ITCZ, MCZ, and PMR all caused an inhibition circle.
1 . PMR
(5%)
2 . AMPH-B
(0.05%)
3 . FLCZ
(0.1%)
4 . MCZ
(0.1%)
5 . VCZ
(0.05%)
6 . MCFG
(0.1%)
: Indicates the center of the topical antimycoticdropClinical Ophthalmology 2008:2(3) 678
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as the sensitivity judged by the CLSI standard is based upon 
serum concentrations, which might not always be identical 
to the sensitivity of the topically applied antimycotic agents. 
Although MCZ, PMR, ITCZ were also effective in the treat-
ment of our patient, the result of sensitivity test using disk 
method indicates that VCZ was the most effective agent for 
B. bassiana infections.
It is also important to emphasize two characteristics of 
B. bassiana keratomycosis that were observed in our patient. 
First, we clinically noted that the keratomycosis caused by 
B. bassiana was restricted to the superﬁ  cial cornea. This dif-
fers from other ﬁ  lamentous fungi, as the pathogenesis for B. 
bassiana is relatively weak and does not cause severe stromal 
inﬁ  ltration or anterior chamber inﬂ  ammation, as has been 
reported for the rabbit model (Ishibashi et al 1987). Since the 
lesion caused by B. bassiana extended horizontally and not 
vertically within the stroma, endothelial plaque and anterior 
inﬂ  ammation were not evoked. On the contrary, Aspergillus 
and Fusarium, which are representative ﬁ  lamentous fungi 
of keratomycosis, will in general quickly invade deeply 
into the corneal stroma and induce endothelial plaque and 
hypopyon.
The second notable characteristic of B. bassiana in slide 
cultures is the presence of septate hyphae with budding and 
zigzag ﬁ  laments at the apex. This characteristic appearance 
can be used to distinguish it from the features of Aspergillus 
and Fusarium. Thus, an early smear diagnosis based on these 
characteristics might help to ensure a successful treatment 
with antimycotic agents.
We were not able to determine how this organism reached 
the patient’s eye. However, B. bassiana is found in plants and 
in the soil, and because this organism is entomopathogenic, 
it is used as a biologic for pesticides (Posada et al 2007; 
Safavi et al 2007) Thus, the possibility exists that while the 
patient was working outdoors, the frame of her eyeglasses 
was contaminated and upon the ocular injury that was caused 
by the frame of her eyeglasses, the fungi were able to invade 
through the damaged tissue. Our patient had a long history 
of recurrent diabetic iritis and continuously used topical 
corticosteroid. This immunocompromized situation also 
triggered the colonization of the fungi.
In conclusion, a weak pathogenic ﬁ  lamentous fungus with 
zig-zag rachis and budding, as determined by smear, may 
account for B. bassiana. VCZ proved to be a powerful tool 
that not only was successfully used in the current case, but 
also in the future might be an agent that can be used thera-
peutically to treat similarly infected types of patients.
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